Inherent
Inherent
AI-native science startup building novel inventions and innovations through advanced AI systems.
About
Inherent is an AI research institution focused on recursively self-improving AI to discover new knowledge. They are building a new kind of AI and research institution to enable a collective intelligence that leverages human and machine strengths for scientific discovery. Their approach reimagines the foundations of science and collaboration to safely realize the promise of AI in invention. Teams look it up for Frontier AI Lab, AI-native science, Foundation Model.
Recursion Pharmaceuticals uses AI and automation for drug discovery, while Inherent aims for a broader 'AI-native science' approach across multiple disciplines, including drug discovery.
Google DeepMind conducts advanced AI research, including work on self-improving AI and scientific discovery, directly competing with Inherent's focus on recursively self-improving AI for new knowledge.
Microsoft Research AI focuses on various AI research areas, including agent research and collaborations with universities, which could overlap with Inherent's goal of developing general-purpose inventive AI.
Inherent's AI-native science platform, particularly its 'Faraday' system, could accelerate the discovery of new drugs and materials, addressing the challenge of slowing scientific progress in areas like drug discovery.
Inherent's general-purpose inventive AI and generative design capabilities could be applied to discover novel materials and optimize their properties, similar to how generative design is used for structural joints.
Inherent's vision of a collective intelligence leveraging human and machine strengths for scientific discovery aligns with the goals of academic institutions seeking to push the boundaries of knowledge.
Inherent's focus on AI-native science and accelerating research across domains would be highly relevant to biotech companies aiming for novel inventions and innovations.
Inherent's emphasis on open-ended exploration and tackling 'unknown-unknowns' in scientific discovery could benefit government labs focused on long-horizon, foundational research.
Buyer fit inferred by StartupHub from what Inherent sells and public signals about each company. Only rows badged "already a customer" are confirmed relationships.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
